Advancing Genetic Discoveries for Inherited Retinal Diseases
For members of the inherited retinal disease (IRD) community, securing an accurate genetic diagnosis is a critical first step toward accessing clinical trials and emerging gene therapies. According to recent reporting from the Index-Journal, Dr. Gavin Arno, Associate Director of Research at the Greenwood Genetic Center (GGC), has been awarded a three-year, $300,000 Individual Investigator Research Award from the Foundation Fighting Blindness to help address this diagnostic challenge.
The funding will support a project titled “Discovering New Mechanisms of Inherited Retinal Dystrophy Using Targeted and Genome-Wide Long-Read Sequencing”. Dr. Arno and his team will utilize advanced DNA sequencing technologies to investigate disease-causing genetic changes that frequently evade detection through standard, conventional testing methods.
Impact on Patients and Families
Inherited retinal dystrophies comprise a group of genetic conditions characterized by progressive retinal damage, leading to vision loss and eventual blindness. While hundreds of genes have been successfully linked to these disorders, a significant portion of patients never receive a definitive genetic diagnosis. As noted by GGC, this diagnostic gap can prevent affected individuals from qualifying for clinical trials or receiving appropriate genetic counseling. By leveraging long-read sequencing, the research aims to uncover hidden genetic variations, better understand how these variants disrupt normal gene function, and ultimately help close the diagnostic gap for families.
Looking Ahead
Dr. Arno's project builds upon previous research supported by the National Institutes of Health. As the work progresses, the findings are expected to enhance the scientific understanding of IRD mechanisms and support the broader efforts of the Foundation Fighting Blindness to accelerate diagnostics, treatments, and cures for retinal degenerative conditions.